Raymond Joseph Tesi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Raymond Joseph Tesi
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Raymond Joseph Tesi

Form 4 holding President and CEO, Director, 10%+ Owner

Inmune Bio, Inc.

Security class
Common Stock
Shares / value
1,554,106
Estimated value
$9,907,426
Report date
12 Sep 2024
Price
$6.38
Ownership
Direct
Form 4 holding President and CEO, Director, 10%+ Owner

Inmune Bio, Inc.

Security class
Option (right to buy)
Shares / value
226,000
Estimated value
Report date
05 Dec 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director, 10%+ Owner

Inmune Bio, Inc.

Security class
Option (right to buy)
Shares / value
37,882
Estimated value
Report date
10 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director, 10%+ Owner

Inmune Bio, Inc.

Security class
Common Stock Warrants (right to buy)
Shares / value
15,380
Estimated value
Report date
12 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Raymond Joseph Tesi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .